$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Geron Corporation
(NASDAQ : GERN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Loading GERN News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.13%80.181.6%$833.53m
BIIBBiogen Inc.
0.84%309.421.2%$602.13m
AMGNAmgen Inc.
0.59%171.231.0%$514.98m
CELGCelgene Corporation
0.80%108.770.8%$486.82m
MDVNMedivation, Inc.
0.00%80.241.8%$432.24m
REGNRegeneron Pharmaceuticals, Inc.
-0.04%400.083.4%$315.08m
ILMNIllumina, Inc.
0.90%171.004.4%$232.42m
BMRNBioMarin Pharmaceutical Inc.
-0.01%94.963.6%$200.83m
ALXNAlexion Pharmaceuticals, Inc.
0.34%129.612.6%$192.98m
VRTXVertex Pharmaceuticals Incorporated
0.39%96.762.3%$118.46m
INCYIncyte Corporation
1.14%81.022.6%$105.54m
IONSIonis Pharmaceuticals, Inc.
1.00%30.6811.1%$95.15m
AAgilent Technologies, Inc.
0.38%47.440.9%$93.90m
EXASExact Sciences Corporation
0.05%19.0630.9%$93.37m
TSROTESARO, Inc.
0.17%85.3815.8%$87.74m

Company Profile

Geron Corp. discovers and develops therapeutic products for cancer. It is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. Geron was founded by Michael D. West on November 28, 1990 and is headquartered in Menlo Park, CA.